Thrombotic Disorders and Laboratory Assessment Flashcards
1
Q
- What is the prevalence of venous thrombosis in the United
States?
a. 0.01
b. 1 in 1000
c. 10% to 15%
d. 500,000 cases per year
A
b. 1 in 1000
2
Q
- What is thrombophilia?
a. Predisposition to thrombosis secondary to a congenital
or acquired disorder
b. Inappropriate triggering of the plasma coagulation system
c. A condition in which clots form uncontrollably
d. Inadequate fibrinolysis
A
a. Predisposition to thrombosis secondary to a congenital
or acquired disorder
3
Q
- What acquired thrombosis risk factor is assessed in the
hemostasis laboratory?
a. Smoking
b. Immobilization
c. Body mass index
d. Lupus anticoagulant
A
d. Lupus anticoagulant
4
Q
- Trousseau syndrome, a low-grade chronic DIC, is often
associated with what type of disorder?
a. Renal disease
b. Hepatic disease
c. Adenocarcinoma
d. Chronic inflammation
A
c. Adenocarcinoma
5
Q
- What is the most common heritable thrombosis risk factor
in Caucasians?
a. APC resistance (factor V Leiden mutation)
b. Prothrombin G20210A mutation
c. Antithrombin deficiency
d. Protein S deficiency
A
a. APC resistance (factor V Leiden mutation)
6
Q
- In most LA profiles, what screening test is primary because
it detects LA with the fewest interferences?
a. Low-phospholipid PTT
b. DRVVT
c. KCT
d. PT
A
b. DRVVT
7
Q
- A patient with venous thrombosis is tested for protein S
deficiency. The protein S activity, antigen, and free antigen
all are less than 65%, and the C4bBP level is normal. What
type of deficiency is likely?
a. Type I
b. Type II
c. Type III
d. No deficiency is indicated, because the reference range
includes 65%.
A
a. Type I
8
Q
- An elevated level of what fibrinolytic system assay is associated with arterial thrombotic risk?
a. PAI-1
b. TPA
c. Factor VIIa
d. Factor XII
A
a. PAI-1
9
Q
- How does lipoprotein (a) cause thrombosis?
a. It causes elevated factor VIII levels.
b. It coats the endothelial lining of arteries.
c. It substitutes for plasminogen or TPA in the forming
clot.
d. It contributes additional phospholipid in vivo for formation of the Xase complex.
A
c. It substitutes for plasminogen or TPA in the forming
clot.
10
Q
- What test may be used to confirm the presence of LA?
a. PT
b. Bethesda titer
c. Antinuclear antibody
d. PTT using high-phospholipid reagent
A
d. PTT using high-phospholipid reagent
11
Q
- What molecular test may be used to confirm APC resistance?
a. Prothrombin G20210A
b. MTHFR 1298
c. MTHFR 677
d. FVL
A
d. FVL
12
Q
- What therapeutic agent may occasionally cause DIC?
a. Factor VIII
b. Factor VIIa
c. Antithrombin concentrate
d. Activated prothrombin complex concentrate
A
d. Activated prothrombin complex concentrate
13
Q
- Which is not a fibrinolysis control protein?
a. Thrombin-activatable fibrinolysis inhibitor
b. Plasminogen activator inhibitor-1
c. a2-antiplasmin
d. D-dimer
A
d. D-dimer
14
Q
- What is the most important application of the quantitative
D-dimer test?
a. Diagnose primary fibrinolysis
b. Diagnose liver and renal disease
c. Rule out deep venous thrombosis
d. Diagnose acute myocardial infarction
A
c. Rule out deep venous thrombosis